Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial. (Q45969997)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial. |
scientific article |
Statements
1 reference
Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial. (English)
1 reference
Karim Fizazi
1 reference
Linda Bosserman
1 reference
Guozhi Gao
1 reference
Tomas Skacel
1 reference
Richard Markus
1 reference
13 June 2009
1 reference
1 reference
182
1 reference
2
1 reference
509-15; discussion 515-6
1 reference
Identifiers
1 reference
1 reference